Tyrosine

Tyrosine

SCHEMBL271920

NC(CO)C(=O)O.NC(Cc1ccc(O)cc1)C(=O)O

nearest known ligand 0.86

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 3/20 0.86
PTGS1 P23219 3/20 0.61
ALPI P09923 1/20 0.61
PKM P14618 1/20 0.61
XIAP P98170 1/20 0.61
ALOX15 P16050 3/20 0.57
HIF1A Q16665 3/20 0.57
KDM4E B2RXH2 2/20 0.57
TDP1 Q9NUW8 2/20 0.57
USP2 O75604 1/20 0.57
EGFR P00533 1/20 0.57
LCK P06239 1/20 0.57
FYN P06241 1/20 0.57
ADORA3 P0DMS8 1/20 0.57
HTR2A P28223 1/20 0.57
PTGS2 P35354 1/20 0.57
RECQL P46063 1/20 0.57
HSD17B10 Q99714 1/20 0.57
TPH1 P17752 1/20 0.53
GRB2 P62993 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tyrosine SCHEMBL271922 1.00 SLC7A5 (0.86) SLC7A5PTGS1ALPIPKMXIAP
Tyrosine SCHEMBL1537214 1.00 SLC7A5 (0.86) SLC7A5PTGS1ALPIPKMXIAP
Tyrosine SCHEMBL1537209 1.00 SLC7A5 (0.86) SLC7A5PTGS1ALPIPKMXIAP
Tyrosine SCHEMBL28549527 1.00 SLC7A5 (0.86) SLC7A5PTGS1ALPIPKMXIAP
Tyrosine SCHEMBL9073603 0.95 SLC7A5 (0.77) SLC7A5PTGS1ALPIPKMXIAP
Tyrosine SCHEMBL25308979 0.94 SLC7A5 (0.75) SLC7A5PTGS1ALPIPKMXIAP
Tyrosine SCHEMBL1326391 0.94 SLC7A5 (0.75) SLC7A5PTGS1ALPIPKMXIAP
Tyrosine SCHEMBL10978820 0.93 SLC7A5 (1.00) SLC7A5PTGS1ALPIPKMXIAP
Tyrosine SCHEMBL1581 0.93 SLC7A5 (1.00) SLC7A5PTGS1ALPIPKMXIAP
Tyrosine SCHEMBL1580 0.93 SLC7A5 (1.00) SLC7A5PTGS1ALPIPKMXIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110542731-A Fingerprint detection method of white ginseng fungus HUNAN YUSHAN YUYUE AGRICULTURAL TECH CO LTD 2019-12-06 CN claimed
US-20090105134-A1 C-Terminally Pegylated Growth Hormones NOVO NORDISK A/S (DK) 2009-04-23 US claimed
EP-1292615-B1 MODIFIED MORBILLIVIRUS V PROTEINS WYETH CORP (US) 2006-10-25 EP claimed
US-6664066-B2 Mutant measles virus V protein; gene expression and engineering WYETH HOLDINGS CORPORATION 2003-12-16 US claimed
US-20030206925-A1 MODIFIED MORBILLIVIRUS V PROTEINS WYETH HOLDINGS CORPORATION 2003-11-06 US claimed
CN-1294628-A Mutations causing attenuation of measles virus or human respiratory syncytial virus subgroup B AMERICAN CYANAMID CO (US) 2001-05-09 CN claimed
WO-2024064233-A1 NEAR-INFRARED IMAGING AGENT AND USES THEREOF CASE WESTERN RESERVE UNIVERSITY (US) 2024-03-28 WO disclosed
WO-2024047497-A1 TREATMENTS FOR PRURIGO NODULARIS Galderma Holding SA (CH) 2024-03-07 WO disclosed
US-11891598-B2 Means and methods for producing phosphate containing capsular polysaccharides MEDIZINISCHE HOCHSCHULE HANNOVER (MHH) (DE) 2024-02-06 US disclosed
US-20230285606-A1 METHODS AND AGENTS FOR THE DETECTION AND TREATMENT OF CANCER UNIV CASE WESTERN RESERVE (US) 2023-09-14 US disclosed
CN-116437812-A Beverage with enhanced sweetness 三得利控股株式会社 2023-07-14 CN disclosed
EP-4192584-A2 METHODS AND AGENTS FOR THE DETECTION AND TREATMENT OF CANCER CASE WESTERN RESERVE UNIVERSITY (US) 2023-06-14 EP disclosed
CN-116209362-A Beverage with enhanced sweetness 三得利控股株式会社 2023-06-02 CN disclosed
WO-2000049889-A1 ANIMAL FEED SUPPLEMENT FOR THE NUTRITIONAL ENRICHMENT OF ANIMAL PRODUCE BARTLETT GRAIN PTY. LTD. (AU) 2000-08-31 WO disclosed
EP-1015488-A1 INTERLEUKIN-17 RECEPTOR-LIKE PROTEIN HUMAN GENOME SCIENCES, INC. (US) 2000-07-05 EP disclosed
WO-2000015759-A1 INTERLEUKIN 17-LIKE RECEPTOR PROTEIN HUMAN GENOME SCIENCES, INC. (US) 2000-03-23 WO disclosed
CN-1227501-A Long-acting drugs and pharmaceutical compositions comprising them YEDA RES & DEV (IL) 1999-09-01 CN disclosed
CN-1217916-A Oral medicinal liquor prepared from Armilariella tabescens WANG WENXIAN (CN) 1999-06-02 CN disclosed
WO-1999014240-A1 INTERLEUKIN-17 RECEPTOR-LIKE PROTEIN HUMAN GENOME SCIENCES, INC. (US) 1999-03-25 WO disclosed
WO-1998024432-A2 USE OF INDOLINONE COMPOUNDS AS MODULATORS OF PROTEIN KINASES SUGEN, INC. (US) 1998-06-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105134-A1 C-Terminally Pegylated Growth Hormones GHRHR, GHITM, HDGF SLC7A5 1160/4885PTGS1 3835/4885ALPI 2242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.